Significant immunomodulatory and hepatoprotective impacts of Silymarin in MS patients: A double-blind placebo-controlled clinical trial
Faezeh Abbasirad, Vahid Shaygannejad, Fahimeh Hosseininasab, Omid Mirmosayyeb, Behzad Mahaki, Behjat Moayedi, Nafiseh Esmaeil
Topics & Concepts
MedicinePlaceboAdverse effectClinical trialInternal medicineMultiple sclerosisImmune systemLiver functionCytokineGastroenterologyLiver enzymeImmunologyPharmacologyPathologyAlternative medicineSilymarin and Mushroom PoisoningDrug-Induced Hepatotoxicity and ProtectionBerberine and alkaloids research